Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of moduating NAD+ levels in hSOD2-linked ALS mouse models Preclinical Research, CognitionANAD StaffJanuary 31, 2020
Targeting NAD+ in translational research to relieve diseases and conditions of metabolic stress and ageing ReviewANAD StaffJanuary 20, 2020Review
Nicotinamide riboside rescues angiotensin II-induced cerebral small vessel disease in mice Preclinical Research, VitalityANAD StaffJanuary 14, 2020
Short-term NAD+ supplementation prevents hearing loss in mouse models of Cockayne syndrome Preclinical Research, SensoryANAD StaffJanuary 7, 2020
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis ReviewANAD StaffJanuary 7, 2020Review
Nicotinamide riboside enhances mitochondrial proteostasis and adult neurogenesis through activationof mitochondrial unfolded protein response signaling in the brain of ALS SOD1 G93A mice Preclinical Research, CognitionANAD StaffJanuary 1, 2020
Nicotinamide pathway-dependent Sirt1 activation restores calcium homeostasis to achieve neuroprotection in Spinocerebellar Ataxia Type 7 Preclinical Research, LocomotionANAD StaffDecember 16, 2019
NAD+ and Exercise in FA (ExRx in FA) Clinical Studies, Locomotion, RecruitingANAD StaffDecember 10, 2019
Nicotinamide riboside alleviates alcohol-induced depression-like behaviours in C57BL/6J mice by altering the intestinal microbiota associated with microglial activation and BDNF expression Preclinical Research, PsychologicalANAD StaffDecember 3, 2019
Degradation of Extracellular NAD+ intermediates in cultures of human HEK293 cells Preclinical Research, Basic ResearchANAD StaffNovember 29, 2019
NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome Preclinical Research, VitalityANAD StaffNovember 21, 2019
Understanding the physicochemical properties and degradation kinetics of nicotinamide riboside, a promising vitamin B3 nutritional supplement Preclinical Research, Pharmacokinetic/SafetyANAD StaffNovember 21, 2019
Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis Clinical Studies, Vitality, Active - Not RecruitingANAD StaffNovember 18, 2019
High dose of dietary nicotinamide riboside induces glucose intolerance and white adipose tissue dysfunction in mice fed a mildly obesogenic diet Preclinical Research, VitalityANAD StaffOctober 17, 2019
NAD+ repletion inhibits the endothelial-to-mesenchymal transition induced by TGF-ß in endothlial cells through improving mitochondrial unfolded protein response Preclinical Research, VitalityANAD StaffOctober 15, 2019
Rapid differentiation of the human RPE cell line, ARPE-19, induced by nicotinamide Preclinical Research, Basic ResearchANAD StaffOctober 15, 2019
Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults Clinical Studies, Vitality, Not Yet RecruitingANAD StaffOctober 2, 2019
NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy Clinical Studies, Sensory, RecruitingANAD StaffOctober 2, 2019
Nicotinamide Riboside in Hospitalized Patients Clinical Studies, Vitality, RecruitingANAD StaffOctober 1, 2019